Growth Metrics

Protalix BioTherapeutics (PLX) Operating Margin Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -40,178.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 530.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1,211.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 6,993.00
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn 8,830.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 8,830.00
Dec 31, 2025 -9,067.00
Sep 30, 2025 3,397.00
Jun 30, 2025 7,059.00
Mar 31, 2025 -2,936.00
Dec 31, 2024 10,632.00
Sep 30, 2024 3,786.00
Jun 30, 2024 12,460.00
Mar 31, 2024 -9,683.00
Dec 31, 2023 -6,811.00
Sep 30, 2023 569.00
Jun 30, 2023 7,865.00
Mar 31, 2023 -4,733.00
Dec 31, 2022 7,125.00
Sep 30, 2022 -1,120.00
Jun 30, 2022 -1,543.00
Mar 31, 2022 4,139.00
Dec 31, 2021 14,237.00
Sep 30, 2021 54,862.00
Jun 30, 2021 19,357.00
Mar 31, 2021 8,040.00
Dec 31, 2020 54,690.00
Sep 30, 2020 7,925.00
Jun 30, 2020 14,952.00
Mar 31, 2020 40,838.00
Dec 31, 2019 43,477.00
Sep 30, 2019 13,152.00
Jun 30, 2019 51,371.00
Mar 31, 2019 110,516.00
Sep 30, 2018 -18,985.00
Jun 30, 2018 8,177.00
Mar 31, 2018 20,507.00
Mar 31, 2017 -29,010.00
Dec 31, 2016 -62,966.00
Sep 30, 2016 10,480.00
Jun 30, 2016 -25,689.00
Mar 31, 2016 -103,404.00
Sep 30, 2015 -22,510.00
Jun 30, 2015 -45,480.00
Mar 31, 2015 -16,112.00
Mar 31, 2014 2,545.00
Dec 31, 2013 96,301.00
Sep 30, 2013 -15,771.00
Jun 30, 2013 58,507.00